Rethinking Alkylating(-Like) Agents for Solid Tumor Management - Université de Rennes Access content directly
Journal Articles Trends in Pharmacological Sciences Year : 2019

Rethinking Alkylating(-Like) Agents for Solid Tumor Management

Abstract

Although old molecules, alkylating agents and platinum derivatives are still widely used in the treatment of various solid tumors. However, systemic toxicity and cellular resistance mechanisms impede their efficacy. Innovative strategies, including local administration, optimization of treatment schedule/dosage, synergistic combinations, and the encapsulation of bioactive molecules in smart, multifunctional drug delivery systems, have shown promising results in potentiating anticancer activity while circumventing such hurdles. Furthermore, questioning of the old paradigm according to which nuclear DNA is the critical target of their anticancer activity has shed light on subcellular alternative and neglected targets that obviously participate in the mediation of cytotoxicity or resistance. Thus, rethinking of the use of these pivotal antineoplastic agents appears critical to improve clinical outcomes in the management of solid tumors.

Domains

Cancer
Fichier principal
Vignette du fichier
Lajous-2019-Rethinking Alkylating(-Like) Agents for Solid Tumor Management.pdf (1.39 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02121104 , version 1 (16-07-2019)

Identifiers

Cite

Hélène Lajous, Bénédicte Lelièvre, Elodie Vauleon, Philippe Lecomte, Emmanuel Garcion. Rethinking Alkylating(-Like) Agents for Solid Tumor Management. Trends in Pharmacological Sciences, 2019, 40 (5), pp.342-357. ⟨10.1016/j.tips.2019.03.003⟩. ⟨hal-02121104⟩
321 View
316 Download

Altmetric

Share

Gmail Facebook X LinkedIn More